Capecitabine (Shilpa Medicare Limited)
Welcome to the PulseAid listing for the Capecitabine drug offered from Shilpa Medicare Limited. This Nucleic Acid Synthesis Inhibitors [MoA],Nucleoside Metabolic Inhibitor [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Shilpa Medicare Limited |
| NON-PROPRIETARY NAME: | Capecitabine |
| SUBSTANCE NAME: | CAPECITABINE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Nucleic Acid Synthesis Inhibitors [MoA],Nucleoside Metabolic Inhibitor [EPC] |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET, FILM COATED |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2016-12-31 |
| END MARKETING DATE: | 0000-00-00 |
Capecitabine HUMAN PRESCRIPTION DRUG Details:
| Item Description | Capecitabine from Shilpa Medicare Limited |
| LABELER NAME: | Shilpa Medicare Limited |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 150(mg/1) |
| START MARKETING DATE: | 2016-12-31 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 63759-3000_35f3619e-3301-4410-8de1-33ae333b56d5 |
| PRODUCT NDC: | 63759-3000 |
| APPLICATION NUMBER: | ANDA207456 |
Other CAPECITABINE Pharmaceutical Manufacturers / Labelers:
